155 related articles for article (PubMed ID: 19552638)
21. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.
Alexy T; Tucker S; Boyle S; Rowe VL; Weaver FA; Liebman HA
J Vasc Surg; 2008 Aug; 48(2):377-81. PubMed ID: 18515040
[TBL] [Abstract][Full Text] [Related]
22. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
23. Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
Mehta RH; Ferguson TB; Lopes RD; Hafley GE; Mack MJ; Kouchoukos NT; Gibson CM; Harrington RA; Califf RM; Peterson ED; Alexander JH;
Circulation; 2011 Jul; 124(3):280-8. PubMed ID: 21709060
[TBL] [Abstract][Full Text] [Related]
24. Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery.
Francis JL; Palmer GJ; Moroose R; Drexler A
Ann Thorac Surg; 2003 Jan; 75(1):17-22. PubMed ID: 12537186
[TBL] [Abstract][Full Text] [Related]
25. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
[TBL] [Abstract][Full Text] [Related]
26. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.
Boonyawat K; Angchaisuksiri P; Aryurachai K; Chaiyaroj S; Ahmadi Z; Chong BH
Thromb Res; 2014 Nov; 134(5):957-62. PubMed ID: 25204999
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.
Pouplard C; May MA; Iochmann S; Amiral J; Vissac AM; Marchand M; Gruel Y
Circulation; 1999 May; 99(19):2530-6. PubMed ID: 10330384
[TBL] [Abstract][Full Text] [Related]
28. Intensive versus moderate statin therapy and early graft occlusion after coronary bypass surgery: The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events randomized clinical trial.
Kulik A; Abreu AM; Boronat V; Ruel M
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):151-161.e1. PubMed ID: 30122341
[TBL] [Abstract][Full Text] [Related]
29. Patency of the saphenous vein conduit anastomosed to the aortic dacron graft.
Kara I; Koksal C; Boyacioglu K; Ay Y; Yanartas M; Metin Esen A
J Cardiovasc Surg (Torino); 2013 Oct; 54(5):647-52. PubMed ID: 24002395
[TBL] [Abstract][Full Text] [Related]
30. Sequential Versus Individual Saphenous Vein Grafting During Coronary Arterial Bypass Surgery.
Park SJ; Kim HJ; Kim JB; Jung SH; Choo SJ; Lee JW; Chung CH
Ann Thorac Surg; 2020 Apr; 109(4):1165-1173. PubMed ID: 31539513
[TBL] [Abstract][Full Text] [Related]
31. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study).
Deb S; Cohen EA; Singh SK; Une D; Laupacis A; Fremes SE;
J Am Coll Cardiol; 2012 Jul; 60(1):28-35. PubMed ID: 22742399
[TBL] [Abstract][Full Text] [Related]
32. Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.
Rollin J; Charuel N; Gruel Y; Billy S; Guéry EA; May MA; Pouplard C; Vayne C
J Thromb Haemost; 2022 Nov; 20(11):2646-2655. PubMed ID: 35971886
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.
Zhao D; Sun X; Yao L; Lin H; Li J; Zhao J; Zhang Z; Lun L; Zhang J; Li M; Huang Q; Yang Y; Jiang S; Wang Y; Zhu H; Chen X
PLoS One; 2013; 8(4):e62239. PubMed ID: 23646121
[TBL] [Abstract][Full Text] [Related]
34. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
35. A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.
Taggart DP; Ben Gal Y; Lees B; Patel N; Webb C; Rehman SM; Desouza A; Yadav R; De Robertis F; Dalby M; Banning A; Channon KM; Di Mario C; Orion E
Ann Thorac Surg; 2015 Jun; 99(6):2039-45. PubMed ID: 25886810
[TBL] [Abstract][Full Text] [Related]
36. Impact of the size mismatch between saphenous vein graft and coronary artery on graft patency.
Yamane Y; Uchida N; Okubo S; Morimoto H; Mukai S
Gen Thorac Cardiovasc Surg; 2017 Jan; 65(1):25-31. PubMed ID: 27485249
[TBL] [Abstract][Full Text] [Related]
37. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
[TBL] [Abstract][Full Text] [Related]
38. Serotonin-release assay-negative heparin-induced thrombocytopenia.
Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
[TBL] [Abstract][Full Text] [Related]
39. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
40. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
